Treating Myomatous Erythrocytosis Syndrome With Uterine Artery Embolization.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31135745.
- Also identified by DOI 10.1097/AOG.0000000000003289.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Myomatous erythrocytosis syndrome, a form of secondary polycythemia associated with uterine leiomyomas, increases the risk of thrombosis and traditionally has been treated with hysterectomy. The patient is a 68-year-old woman with 7-year history of polycythemia initially thought to be secondary to a gastrointestinal stromal tumor that persisted after resection. A subsequent search for an alternative etiology led to the discovery of an 11.2-cm submucosal leiomyoma and likelihood of myomatous erythrocytosis syndrome. The patient declined surgical management and continued to undergo recurrent phlebotomy to maintain a hematocrit of less than 45% until consultation with an interventional radiology specialist. She underwent uterine artery embolization in July 2017, and her hematocrit has remained within normal limits through 17 months of follow-up. Uterine artery embolization is an effective alternative treatment modality for myomatous erythrocytosis syndrome.
Medical subject headings
- Leiomyoma
- Polycythemia
- Uterine Artery Embolization
- Uterine Neoplasms